New rival to Gilead hepatitis C drug approved

December 20, 2014 1:39 AM

16 0

TRENTON, N.J. -- Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

The Food and Drug Administration on Friday approved the sale of a packaged treatment called Viekira Pak made by AbbVie Inc. of North Chicago, Illinois.

Read more

To category page